Taich Adam 4

What Happened

• Adam Taich, Chief Financial Officer of 10x Genomics (TXG), sold 15,098 shares on May 22, 2026 in an open-market/private sale at $24.44 per share, generating proceeds of $369,018. This was a sale (not a purchase) and was executed to satisfy tax withholding related to the vesting of restricted stock units.

Key Details

• Transaction date: 2026-05-22
• Price per share: $24.44
• Shares sold: 15,098
• Gross proceeds: $369,018
• Footnote: Shares were sold to cover tax withholding obligations in connection with RSU vesting (per filing footnote F1)
• Filing date: 2026-05-27 (filed five days after the reported transaction; Form 4s are typically due within 2 business days — check the EDGAR filing for any late-reporting notation)
• Shares owned after transaction: not specified in the summary data provided (see the Form 4 on EDGAR for exact post-transaction holdings)

Context

• Sales to cover tax withholding on vested RSUs are routine and common; they generally reflect administrative needs to pay taxes rather than a directional bet on the stock.
• For retail investors, purchases by insiders tend to be more informative than routine sell-to-cover transactions.